{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:18:41Z","timestamp":1788452321743,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pet.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["PET Clinics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cpet.2026.05.005","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:51:36Z","timestamp":1784667096000},"page":"511-520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["2-[18F]fluoro-2-deoxy-d-glucose PET in Brain Tumors"],"prefix":"10.1016","volume":"21","author":[{"given":"Camille","family":"Steenhout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Hustinx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew B.","family":"Newberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abass","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Withofs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cpet.2026.05.005_bib1","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ncl.2016.06.014","article-title":"Epidemiology of brain tumors","volume":"34","author":"McNeill","year":"2016","journal-title":"Neurol Clin"},{"issue":"Supplement_5","key":"10.1016\/j.cpet.2026.05.005_bib2","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012\u20132016","volume":"21","author":"Ostrom","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.cpet.2026.05.005_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/B978-0-12-811161-1.00002-5","article-title":"Brain metastases: epidemiology","volume":"149","author":"Ostrom","year":"2018","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"10.1016\/j.cpet.2026.05.005_bib4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","article-title":"EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood","volume":"18","author":"Weller","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"10.1016\/j.cpet.2026.05.005_bib5","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3390\/cancers14051103","article-title":"PET imaging in neuro-oncology: an update and overview of a rapidly growing area","volume":"14","author":"Verger","year":"2022","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.cpet.2026.05.005_bib6","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1053\/j.semnuclmed.2008.02.005","article-title":"Advances in evaluation of primary brain tumors","volume":"38","author":"Chen","year":"2008","journal-title":"Semin Nucl Med"},{"issue":"2","key":"10.1016\/j.cpet.2026.05.005_bib7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/PPO.0000000000000105","article-title":"Imaging tumor metabolism using positron emission tomography","volume":"21","author":"Lewis","year":"2015","journal-title":"Cancer J"},{"issue":"12","key":"10.1016\/j.cpet.2026.05.005_bib8","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1007\/s00259-025-07366-0","article-title":"Availability and use of PET in patients with brain tumours \u2013 a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) survey","volume":"52","author":"Mair","year":"2025","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"10","key":"10.1016\/j.cpet.2026.05.005_bib9","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1093\/neuonc\/noaf170","article-title":"Update to the RANO working group and EANO recommendations for the clinical use of PET imaging in gliomas","volume":"27","author":"Galldiks","year":"2025","journal-title":"Neuro Oncol"},{"issue":"6","key":"10.1016\/j.cpet.2026.05.005_bib10","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1053\/j.sult.2020.08.007","article-title":"PET and SPECT imaging of brain tumors","volume":"41","author":"Zhang","year":"2020","journal-title":"Semin Ultrasound CT MRI"},{"key":"10.1016\/j.cpet.2026.05.005_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","author":"Warburg","year":"1956","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.cpet.2026.05.005_bib12","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1053\/j.semnuclmed.2017.05.005","article-title":"Small molecule PET tracers for transporter imaging","volume":"47","author":"Kilbourn","year":"2017","journal-title":"Semin Nucl Med"},{"issue":"5","key":"10.1016\/j.cpet.2026.05.005_bib13","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neurol.2023.03.002","article-title":"Contribution of nuclear medicine to the diagnosis and management of primary brain tumours","volume":"179","author":"Horowitz","year":"2023","journal-title":"Rev Neurol (Paris)"},{"issue":"Supplement 2","key":"10.1016\/j.cpet.2026.05.005_bib14","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.2967\/jnumed.124.268754","article-title":"SNMMI procedure Standard\/EANM practice guideline for brain [18F]FDG PET Imaging, Version 2.0","volume":"66","author":"Arbizu","year":"2025","journal-title":"J Nucl Med"},{"issue":"8","key":"10.1016\/j.cpet.2026.05.005_bib15","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.cpet.2026.05.005_bib16","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/neuonc\/nov148","article-title":"Performance of 18F-FET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: systematic review and meta-analysis","volume":"18","author":"Dunet","year":"2016","journal-title":"Neuro Oncol"},{"issue":"9","key":"10.1016\/j.cpet.2026.05.005_bib17","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/neuonc\/now058","article-title":"Response assessment in neuro-oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas","volume":"18","author":"Albert","year":"2016","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.cpet.2026.05.005_bib18","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s11060-011-0771-6","article-title":"Independent prognostic value of pre-treatment 18-FDG-PET in high-grade gliomas","volume":"107","author":"Colavolpe","year":"2012","journal-title":"J Neuro Oncol"},{"issue":"3","key":"10.1016\/j.cpet.2026.05.005_bib19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cpet.2022.03.004","article-title":"Facts and fictions about [18F]FDG versus other tracers in managing patients with brain tumors","volume":"17","author":"Withofs","year":"2022","journal-title":"Pet Clin"},{"issue":"1","key":"10.1016\/j.cpet.2026.05.005_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1148\/radiology.195.1.7892494","article-title":"Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET","volume":"195","author":"Delbeke","year":"1995","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.cpet.2026.05.005_bib21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/RLU.0000000000002460","article-title":"Pattern of FDG and MET distribution in High- and low-grade gliomas on PET images","volume":"44","author":"Takahashi","year":"2019","journal-title":"Clin Nucl Med"},{"issue":"4","key":"10.1016\/j.cpet.2026.05.005_bib22","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2214\/AJR.19.22571","article-title":"The role of dual-phase FDG PET\/CT in the diagnosis and follow-up of brain tumors","volume":"215","author":"\u00d6z\u00fctemiz","year":"2020","journal-title":"Am J Roentgenol"},{"issue":"8","key":"10.1016\/j.cpet.2026.05.005_bib23","doi-asserted-by":"crossref","first-page":"e436","DOI":"10.1016\/S1470-2045(25)00193-7","article-title":"Update to the RANO working group and EANO recommendations for the clinical use of PET imaging in gliomas","volume":"26","author":"Galldiks","year":"2025","journal-title":"Lancet Oncol"},{"issue":"15","key":"10.1016\/j.cpet.2026.05.005_bib24","doi-asserted-by":"crossref","first-page":"e534","DOI":"10.1016\/S1470-2045(15)00088-1","article-title":"Immunotherapy response assessment in neuro-oncology: a report of the RANO working group","volume":"16","author":"Okada","year":"2015","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.cpet.2026.05.005_bib25","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/neuonc\/noz003","article-title":"PET imaging in patients with brain metastasis\u2014report of the RANO\/PET group","volume":"21","author":"Galldiks","year":"2019","journal-title":"Neuro Oncol"},{"issue":"5","key":"10.1016\/j.cpet.2026.05.005_bib26","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1007\/s00259-024-07038-5","article-title":"Joint EANM\/EANO\/RANO\/SNMMI practice guideline\/procedure standard for PET imaging of brain metastases: version 1.0","volume":"52","author":"Verger","year":"2025","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"1","key":"10.1016\/j.cpet.2026.05.005_bib27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11060-010-0365-8","article-title":"Dual phase FDG-PET imaging of brain metastases provides superior assessment of recurrence versus post-treatment necrosis","volume":"103","author":"Horky","year":"2011","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.cpet.2026.05.005_bib28","article-title":"[68Ga]Ga-FAPI PET\/CT in brain tumors: comparison with [18F]F-FDG PET\/CT","volume":"14","author":"Liu","year":"2024","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.cpet.2026.05.005_bib29","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00259-025-07576-6","article-title":"Revealing the hidden: a systematic review and meta-analysis of FAPI-based tracers imaging for brain metastatic lesions","volume":"53","author":"Sadeghpour","year":"2026","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"8","key":"10.1016\/j.cpet.2026.05.005_bib30","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","article-title":"Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer","volume":"47","author":"Chen","year":"2020","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"12","key":"10.1016\/j.cpet.2026.05.005_bib31","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3390\/diagnostics10121076","article-title":"Primary central nervous system lymphomas: a diagnostic overview of key histomorphologic, immunophenotypic, and genetic features","volume":"10","author":"Lauw","year":"2020","journal-title":"Diagnostics"},{"issue":"7","key":"10.1016\/j.cpet.2026.05.005_bib32","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/neuonc\/noae029","article-title":"Interim FDG-PET improves treatment failure prediction in primary central nervous system lymphoma: an LOC network prospective multicentric study","volume":"26","author":"Rozenblum","year":"2024","journal-title":"Neuro Oncol"},{"issue":"17","key":"10.1016\/j.cpet.2026.05.005_bib33","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.3390\/cancers14174071","article-title":"Role of positron emission tomography in primary central nervous system lymphoma","volume":"14","author":"Rozenblum","year":"2022","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.cpet.2026.05.005_bib34","first-page":"325","article-title":"R\u00f4le de la TEP en neuro-oncologie : apport des traceurs FDG, aux acides amin\u00e9s et des r\u00e9cepteurs de la somatostatine dans la prise en charge des tumeurs c\u00e9r\u00e9brales","volume":"49","author":"Verger","year":"2025","journal-title":"Med Nucl"},{"issue":"12","key":"10.1016\/j.cpet.2026.05.005_bib35","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1007\/s00259-023-06334-w","article-title":"[18F]FDG PET-MRI provides survival biomarkers in primary central nervous system lymphoma in the elderly: an ancillary study from the BLOCAGE trial of the LOC network","volume":"50","author":"Rozenblum","year":"2023","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"7","key":"10.1016\/j.cpet.2026.05.005_bib36","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/neuonc\/noab020","article-title":"Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG)","volume":"23","author":"Barajas","year":"2021","journal-title":"Neuro Oncol"},{"issue":"5","key":"10.1016\/j.cpet.2026.05.005_bib37","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neurol.2023.03.012","article-title":"Recent advances in the diagnosis and the treatment of primary CNS lymphoma","volume":"179","author":"Rachdi","year":"2023","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.cpet.2026.05.005_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.eanmj.2025.100008","article-title":"EANM insights on PET-based response assessment in neuro-oncology: things are moving forward!","volume":"1","author":"Verger","year":"2025","journal-title":"EANM J"},{"key":"10.1016\/j.cpet.2026.05.005_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1137849","article-title":"Intracranial meningiomas: an update of the 2021 World Health Organization classifications and review of management with a focus on radiation therapy","volume":"13","author":"Yarabarla","year":"2023","journal-title":"Front Oncol"},{"issue":"12","key":"10.1016\/j.cpet.2026.05.005_bib40","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1093\/neuonc\/nox112","article-title":"PET imaging in patients with meningioma\u2014report of the RANO\/PET group","volume":"19","author":"Galldiks","year":"2017","journal-title":"Neuro Oncol"},{"issue":"5","key":"10.1016\/j.cpet.2026.05.005_bib41","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/(SICI)1097-0215(19980529)76:5<620::AID-IJC2>3.0.CO;2-S","article-title":"Expression of somatostatin receptor subtypes in human brain tumors","volume":"76","author":"Dutour","year":"1998","journal-title":"Int J Cancer"},{"issue":"12","key":"10.1016\/j.cpet.2026.05.005_bib42","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1007\/s00259-024-06783-x","article-title":"Joint EANM\/EANO\/RANO\/SNMMI practice guideline\/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0","volume":"51","author":"Albert","year":"2024","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"1","key":"10.1016\/j.cpet.2026.05.005_bib43","article-title":"Current status of PET imaging in neuro-oncology","volume":"1","author":"Galldiks","year":"2019","journal-title":"Neuro-Oncol Adv"},{"issue":"2","key":"10.1016\/j.cpet.2026.05.005_bib44","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2967\/jnumed.114.146290","article-title":"Value of 18F-FDG PET and PET\/CT for Evaluationeof Pediatric palignancims","volume":"56","author":"Uslu","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cpet.2026.05.005_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2024.1268038","article-title":"Pediatric CNS tumors and 2021 WHO classification: what do oncologists need from pathologists?","volume":"17","author":"d\u2019Amati","year":"2024","journal-title":"Front Mol Neurosci"},{"issue":"11","key":"10.1016\/j.cpet.2026.05.005_bib46","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1007\/s00259-022-05817-6","article-title":"Joint EANM\/SIOPE\/RAPNO practice guidelines\/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0","volume":"49","author":"Piccardo","year":"2022","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"5","key":"10.1016\/j.cpet.2026.05.005_bib47","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1148\/rg.335125152","article-title":"FDG PET of the brain in pediatric patients: imaging spectrum with MR imaging correlation","volume":"33","author":"Stanescu","year":"2013","journal-title":"Radiographics"},{"issue":"5","key":"10.1016\/j.cpet.2026.05.005_bib48","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1053\/j.semnuclmed.2007.04.002","article-title":"Nuclear medicine in pediatric neurology and neurosurgery: Epilepsy and brain tumors","volume":"37","author":"Patil","year":"2007","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.cpet.2026.05.005_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2021.106669","article-title":"Comparison of brain F-18 FDG PET\/MRI with PET\/CT imaging in pediatric patients","volume":"206","author":"Sager","year":"2021","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"10.1016\/j.cpet.2026.05.005_bib50","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cpet.2025.12.003","article-title":"Management of pediatric brain tumors with the aid of PET\/MR imaging","volume":"21","author":"Aboian","year":"2026","journal-title":"Pet Clin"},{"issue":"3","key":"10.1016\/j.cpet.2026.05.005_bib51","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40336-025-00699-8","article-title":"Diagnostic and prognostic value of [18F] FET PET imaging in pediatric and adolescent brain tumors: a systematic review and meta-analysis","volume":"13","author":"Antonevskaya","year":"2025","journal-title":"Clin Transl Imaging"},{"issue":"5","key":"10.1016\/j.cpet.2026.05.005_bib52","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/j.semnuclmed.2025.06.012","article-title":"Artificial intelligence for tumor [18F]FDG PET imaging: advancements and future trends - part II","volume":"55","author":"Safarian","year":"2025","journal-title":"Semin Nucl Med"}],"container-title":["PET Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859826000507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859826000507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:38:44Z","timestamp":1788449924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556859826000507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1556859826000507"],"URL":"https:\/\/doi.org\/10.1016\/j.cpet.2026.05.005","relation":{},"ISSN":["1556-8598"],"issn-type":[{"value":"1556-8598","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2-[18F]fluoro-2-deoxy-d-glucose PET in Brain Tumors","name":"articletitle","label":"Article Title"},{"value":"PET Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpet.2026.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}